MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12879-026-12622-1

Медицинская библиотека · BMC infectious diseases · 2026

Malondialdehyde, 8-iso-prostaglandin F2α, and lipid profile alterations in COVID-19 patients: insights from South-Western Nigeria.

Ebesunun Maria Onomhaguan, Ozegbe Donatus Uchechukwu, Nwaejigh Promise Chineye, Orimadegun Bose Etaniamhe, Okeoma Obiageri Ihuarulam

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Oxidative stress and lipid metabolism disruptions drive COVID-19 severity, but data from African populations, particularly Nigeria, are limited. This study explored malondialdehyde (MDA), 8-iso-prostaglandin F2α (8-iso-PGF2α), and lipid profile changes in COVID-19 patients in South-Western Nigeria, emphasizing co-infections.

METHODS

This cross-sectional study included 60 COVID-19 patients, with and without comorbidities, and 50 healthy controls at three Lagos isolation centers from July to December 2021. Disease severity (mild, moderate, severe) was assessed using clinical, oxygen saturation, and radiologic criteria. Serum MDA and lipid profiles were measured by spectrophotometry, and 8-iso-PGF2α by enzyme-linked immunosorbent assay. ANOVA with Tukey post-hoc tests analyzed normally distributed variables, and Kruskal–Wallis tests evaluated skewed variables. Age-adjusted comparisons used ANCOVA, with log-transformation for non-normal data. Spearman’s correlation assessed relationships between oxidative stress and lipid parameters, with Bonferroni correction for multiple comparisons.

RESULTS

COVID-19 patients showed elevated MDA, 8-iso-PGF2α, triglycerides, and TG/HDL-C ratios (p ≤ 0.001), and reduced total cholesterol, LDL-C, and HDL-C (p ≤ 0.001) compared to controls. Oxidative stress markers correlated with lipid parameters, suggesting cardiovascular risk. Severe cases and malaria co-infected patients had more pronounced changes, though small subgroup sizes limited findings.

CONCLUSION

COVID-19 in Nigerian patients shows elevated MDA, 8-iso-PGF₂α, and dyslipidaemia (higher triglycerides, TG/HDL-C ratio, lower HDL-cholesterol), worsened by severity and malaria co-infection. These suggest biomarkers for risk stratification and therapy. The cross-sectional design limits causality, requiring larger, prospective studies for metabolic monitoring in co-endemic settings. CLINICAL TRIAL NUMBER: Not applicable.

Для цитирования: Ebesunun Maria Onomhaguan, Ozegbe Donatus Uchechukwu, Nwaejigh Promise Chineye, Orimadegun Bose Etaniamhe, Okeoma Obiageri Ihuarulam. Malondialdehyde, 8-iso-prostaglandin F2α, and lipid profile alterations in COVID-19 patients: insights from South-Western Nigeria.. BMC infectious diseases. 2026. DOI: 10.1186/s12879-026-12622-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.